Profiel
Sophie Binay is currently the General Manager & Chief Scientific Officer at Acticor Biotech SAS. She previously worked as the Director-Nonclinical Research & Development at Minka Therapeutics SA, the VP-Research & Early Clinical Development at PEP-Therapy SAS, and the Head-Translational Programs at Gustave Roussy Institute.
Actieve functies van Sophie Binay
| Bedrijven | Functie | Begin |
|---|---|---|
| ACTICOR BIOTECH | Hoofd Techniek/Wetenschap/O&O | 15-06-2021 |
Eerdere bekende functies van Sophie Binay
| Bedrijven | Functie | Einde |
|---|---|---|
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops a portfolio of therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS | Hoofd Techniek/Wetenschap/O&O | - |
Gustave Roussy Institute | Corporate Officer/Principal | - |
PEP-Therapy SAS
PEP-Therapy SAS BiotechnologyHealth Technology biotechnology development and research. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops a portfolio of therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS | Health Technology |
PEP-Therapy SAS
PEP-Therapy SAS BiotechnologyHealth Technology biotechnology development and research. | Health Technology |
Acticor Biotech SAS
Acticor Biotech SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
Gustave Roussy Institute |
















